title: Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index.
abstract: Non-Hodgkin lymphomas (NHLs) are often present outside the lymph nodes. Although primary extranodal NHLs (PE-NHL) form a substantial part of all NHLs, reports on oral PE-NHLs are rare. Forty patients with PE-NHL of the oral cavity have been studied for the distribution of gender, age, oral subsite and presenting complaint, histological subtype according to the WHO classification, clinical stage, treatment, and follow-up. The data are reviewed against the background of the literature. Furthermore, the International Prognostic Index has been taken into consideration. All patients had a lymphoma of B-cell lineage. Two-thirds of patients presented with locoregional disease. Mean survival time was 38 months, with a mean recurrence-free survival time of 31 months. There was no statistically significant difference in survival time between patients with bone versus soft tissue localisation of the PE-NHL. In view of the rarity of PE-NHL involving the oral region multicenter studies are needed for evaluation of the usefulness of the International Prognostic Index for non-Hodgkin lymphoma in this particular part of the body.
authors.affiliation: Department of Oral and Maxillofacial Surgery, VU University Medical Centre/ACTA, Amsterdam, The Netherlands.
authors.forename: R I F
authors.initials: RI
authors.lastname: van der Waal
authors.forename: P C
authors.initials: PC
authors.lastname: Huijgens
authors.forename: P
authors.initials: P
authors.lastname: van der Valk
authors.forename: I
authors.initials: I
authors.lastname: van der Waal
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000145:classification*; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000145:classification* / Q000473:pathology; D009367:Neoplasm Staging; D010954:Plasmacytoma / Q000473:pathology; D011379:Prognosis; D014944:World Health Organization